IBEX Limited
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $164.3M | $164.4M | $164.2M | $151.2M | $147.1M | $140.7M | $140.7M | $129.7M |
| Cost of Revenue | $117.3M | $115.6M | $116.6M | $106.6M | $100.9M | $96.0M | $98.8M | $90.0M |
| Gross Profit | $46.9M | $48.8M | $47.6M | $44.6M | $46.3M | $44.7M | $41.9M | $39.7M |
| Gross Margin | 28.6% | 29.7% | 29.0% | 29.5% | 31.4% | 31.8% | 29.8% | 30.6% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $31.5M | $27.5M | $27.6M | $26.5M | $29.8M | $27.1M | $25.7M | $26.2M |
| Operating Income | $9.8M | $16.2M | $15.3M | $13.7M | $12.3M | $13.3M | $11.9M | $9.1M |
| Operating Margin | 6.0% | 9.8% | 9.3% | 9.1% | 8.3% | 9.5% | 8.5% | 7.0% |
| Interest Expense | — | — | — | — | — | — | $620.0K | $162.0K |
| Pretax Income | $9.7M | $16.0M | $15.1M | $13.5M | $11.8M | $13.0M | $11.6M | $9.5M |
| Income Tax Expense | $968.0K | $2.6M | $2.9M | $1.5M | $2.2M | $2.5M | $2.4M | $2.0M |
| Net Income | $8.7M | $13.3M | $12.2M | $12.0M | $9.6M | $10.5M | $9.3M | $7.5M |
| Net Margin | 5.3% | 8.1% | 7.4% | 8.0% | 6.5% | 7.4% | 6.6% | 5.8% |
| EPS (Basic) | $0.65 | $0.99 | $0.91 | $0.90 | $0.66 | $0.79 | $0.61 | $0.45 |
| EPS (Diluted) | $0.59 | $0.89 | $0.83 | $0.82 | $0.63 | $0.73 | $0.57 | $0.43 |
| Shares Outstanding (Basic) | 13.4M | 13.5M | 13.5M | 13.4M | 14.7M | 13.3M | 15.1M | 16.9M |
| Shares Outstanding (Diluted) | 14.8M | 15.0M | 14.7M | 14.6M | 15.7M | 14.4M | 16.5M | 17.5M |
| Dividends Per Share | — | — | — | — | — | — | — | — |